Literature DB >> 20384904

Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains.

Huw Bowen Jones1, David Nugent, Richard Jenkins.   

Abstract

Assessment of the histopathological and plasma biochemical characteristics of diabetic and non-diabetic rat strains [Han and AP Wistar, lean and obese Zucker Fatty (ZF), and lean and obese Zucker Diabetic Fatty (ZDF) rats] was performed at 6 or 14 weeks of age. Wistar and lean ZF and ZDF rats showed no or minimal islet pathology or plasma biochemical alterations at both timepoints. Obese ZFs were euglycaemic at both timepoints and mildly and severely hyperinsulinaemic at 6 and 14 weeks respectively. Islet morphology was normal at 6 weeks but at 14 weeks, islet hyperplasia was present with a minority showing degenerative changes namely, beta-cell vacuolation, vascular congestion and haemorrhage with minimal mononuclear cell and T lymphocytic infiltration. Obese ZDFs were euglycaemic and moderately hyperinsulinaemic at 6 weeks and severely hyperglycaemic with minor hypoinsulinaemia at 14 weeks. Obese ZDFs at 6 weeks showed mainly normal islets with some displaying degeneration (ranging from beta-cell vacuolation alone to the features described above). At 14 weeks, islet degeneration was more severe and widespread: beta-cell death was present in numerous islets at low level. Islet beta-cell numbers were reduced or absent (with associated reduction in insulin immunostaining) within the islets that now consisted predominantly of fibroblasts, collagen and mononuclear cells. Fibroproliferation consisting of smooth muscle actin-alpha-positive tissue was associated with mononuclear cell infiltration. Some fibrous scars were visible indicative of lost islets. Islet degeneration in obese ZF and ZDF rats was not accompanied by a reduction in beta-cell proliferation or in compensatory proliferation of beta-cell neogenic clusters. In the light of recent reports of adaptive and inflammation-mediated degenerative changes in human non-insulin dependent diabetes mellitus (NIDDM) islets, the hypertrophy/hyperplasia of beta-cells and islet degeneration involving infiltration by monocyte/macrophages in obese ZF and obese ZDF rats respectively offers substantial potential for elucidation of the processes involved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20384904      PMCID: PMC2884097          DOI: 10.1111/j.1365-2613.2010.00713.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  47 in total

1.  Increased islet blood flow in obese rats: role of the autonomic nervous system.

Authors:  N Atef; A Ktorza; L Picon; L Pénicaud
Journal:  Am J Physiol       Date:  1992-05

2.  Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.

Authors:  A Clark; C A Wells; I D Buley; J K Cruickshank; R I Vanhegan; D R Matthews; G J Cooper; R R Holman; R C Turner
Journal:  Diabetes Res       Date:  1988-12

Review 3.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

4.  Glucose-induced changes in pancreatic islet blood flow mediated by central nervous system.

Authors:  L Jansson; C Hellerström
Journal:  Am J Physiol       Date:  1986-12

Review 5.  Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited.

Authors:  G Klöppel; M Löhr; K Habich; M Oberholzer; P U Heitz
Journal:  Surv Synth Pathol Res       Date:  1985

6.  Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans.

Authors:  Y Stefan; L Orci; F Malaisse-Lagae; A Perrelet; Y Patel; R H Unger
Journal:  Diabetes       Date:  1982-08       Impact factor: 9.461

7.  Chronological characterization of diabetes development in male Spontaneously Diabetic Torii rats.

Authors:  Taku Masuyama; Kajuro Komeda; Akemi Hara; Mitsuhiko Noda; Masami Shinohara; Toshihiro Oikawa; Yasunori Kanazawa; Kazuyuki Taniguchi
Journal:  Biochem Biophys Res Commun       Date:  2004-02-13       Impact factor: 3.575

8.  The diabetic Zucker fatty rat.

Authors:  J B Clark; C J Palmer; W N Shaw
Journal:  Proc Soc Exp Biol Med       Date:  1983-05

9.  Cellular composition of the human diabetic pancreas.

Authors:  J Rahier; R M Goebbels; J C Henquin
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

10.  Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats.

Authors:  S W J Janssen; G J M Martens; C G J Sweep; P N Span; A A J Verhofstad; A R M M Hermus
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256

View more
  16 in total

1.  Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats.

Authors:  Himadri Singh; Sireesha Ganneru; Venkata Malakapalli; Maniprabha Chalasani; Giridharan Nappanveettil; Ramesh R Bhonde; Vijayalakshmi Venkatesan
Journal:  Islets       Date:  2014       Impact factor: 2.694

Review 2.  Targeting Islets: Metabolic Surgery Is More than a Bariatric Surgery.

Authors:  Xi Chen; Jingjing Zhang; Zhiguang Zhou
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

3.  Hydroxychloroquine hindering of diabetic isletopathy carries its signature on the inflammatory cytokines.

Authors:  Ahmed A M Abdel-Hamid; Alaa El-Din L El-Firgany
Journal:  J Mol Histol       Date:  2016-02-13       Impact factor: 2.611

4.  Role of aquaporin-7 in ghrelin- and GLP-1-induced improvement of pancreatic β-cell function after sleeve gastrectomy in obese rats.

Authors:  L Méndez-Giménez; S Becerril; S P Camões; I V da Silva; C Rodrigues; R Moncada; V Valentí; V Catalán; J Gómez-Ambrosi; J P Miranda; G Soveral; G Frühbeck; A Rodríguez
Journal:  Int J Obes (Lond)       Date:  2017-06-06       Impact factor: 5.095

Review 5.  Islet inflammation: a unifying target for diabetes treatment?

Authors:  Yumi Imai; Anca D Dobrian; Margaret A Morris; Jerry L Nadler
Journal:  Trends Endocrinol Metab       Date:  2013-02-26       Impact factor: 12.015

6.  Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes.

Authors:  Matthew J Butcher; Daniel Hallinger; Eden Garcia; Yui Machida; Swarup Chakrabarti; Jerry Nadler; Elena V Galkina; Yumi Imai
Journal:  Diabetologia       Date:  2014-01-16       Impact factor: 10.122

7.  Beta cell dysfunction and insulin resistance.

Authors:  Marlon E Cerf
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-27       Impact factor: 5.555

8.  Characterization of the Prediabetic State in a Novel Rat Model of Type 2 Diabetes, the ZFDM Rat.

Authors:  Ghupurjan Gheni; Norihide Yokoi; Masayuki Beppu; Takuro Yamaguchi; Shihomi Hidaka; Ayako Kawabata; Yoshikazu Hoshino; Masayuki Hoshino; Susumu Seino
Journal:  J Diabetes Res       Date:  2015-04-16       Impact factor: 4.011

9.  Preventive effects of Morus alba L. anthocyanins on diabetes in Zucker diabetic fatty rats.

Authors:  Ariya Sarikaphuti; Thamthiwat Nararatwanchai; Teruto Hashiguchi; Takashi Ito; Sita Thaworanunta; Kiyoshi Kikuchi; Yoko Oyama; Ikuro Maruyama; Salunya Tancharoen
Journal:  Exp Ther Med       Date:  2013-07-04       Impact factor: 2.447

10.  ER stress in rodent islets of Langerhans is concomitant with obesity and β-cell compensation but not with β-cell dysfunction and diabetes.

Authors:  O Omikorede; C Qi; T Gorman; P Chapman; A Yu; D M Smith; T P Herbert
Journal:  Nutr Diabetes       Date:  2013-10-21       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.